Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Last updated on July 2021Recruitment
- Recruitment Status
- Terminated
- Estimated Enrollment
- 600
Summary
- Conditions
- Diabetes Mellitus
- Gastroparesis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Active, not recruiting due to COVID-19
Active, not recruiting due to COVID-19
Tracking Information
- NCT #
- NCT03426345
- Collaborators
- Not Provided
- Investigators
- Study Director: Wieslaw (Wes) Bochenek, MD, PhD Allergan
Get Well Soon